EatDrama
Lifestyle

STAT Plus: FDA pauses Regenxbio gene therapy trial again due to safety concerns 

STAT Plus: FDA pauses Regenxbio gene therapy trial again due to safety concerns 

Five patients were found to have small masses on their spines. Regenxbio has faced previous safety concerns with its gene therapies.

Open original source

Article discussion

Comments stay attached to this story.

No comments yet.

Write a drama, celeb, gossip, or lifestyle post

Start a connected post from this article without changing the original story.

Featured Creators

Creators building their communities through the SpiderTaz Creator Program.

View creators →